AbbVie
The Scientist I, Biopharmaceutics role involves designing, executing, and analyzing studies to characterize the biopharmaceutical properties of drug candidates, supporting early- and late-stage development activities for peptide and small molecule programs. The position requires collaborating with multidisciplinary teams to generate high-quality data, communicate findings, and contribute to informed decision-making for emerging molecules. This role focuses on advancing developability and product performance through scientific rigor and critical thinking.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Director - Dissolution Science & Biopharmaceutics
Eli Lilly and Company
Senior Principal Scientist, Pre-Formulation and Materials Science
Pfizer
Scientist I/II, Technical Development
biogen
Senior Scientist
AstraZeneca
Principal Scientist – Biopharmaceutics Strategy
AstraZeneca
Associate Research Fellow, Early Formulation Science & Drug Delivery
Pfizer